COO vs NRIX · P/E 36, rev $4.09B vs rev $15.3M
The Cooper Companies, Inc (COO) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
COO currently screens at market cap $14.92B and trailing P/E 36.1. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the COO and NRIX stock pages for the full models.
Not investment advice.